Thonburi Medical Center PCL (BKK:KDH) Research & Development: ฿0 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BKK:KDH Thonburi Medical Center PCL BKK:KDH
88 GF Score
Price ฿83.25
GF Value ฿92.61
Valuation Modestly Undervalued
View Full Analysis

What is Thonburi Medical Center PCL Research & Development?

Thonburi Medical Center PCL BKK:KDH 88 Research & Development is ฿0 Mil as of Mar. 2026. GuruFocus rates BKK:KDH with a GF Score™ of 88/100 and a GF Value™ of ฿92.61 (Modestly Undervalued).

Research & Development is the aggregate amount of research and development expenses during the year. Thonburi Medical Center PCL's Research & Development for the three months ended in Mar. 2026 was ฿0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was ฿0 Mil.

Thonburi Medical Center PCL  (BKK:KDH) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Thonburi Medical Center PCL Research & Development Related Terms

Thonburi Medical Center PCL Research & Development Historical Data

* Premium members only.

The historical data trend for Thonburi Medical Center PCL's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Thonburi Medical Center PCL Research & Development Chart

Thonburi Medical Center PCL Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Thonburi Medical Center PCL Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
BKK:KDH
88GF Score
Thonburi Medical Center PCL BKK:KDH
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Thonburi Medical Center PCL Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ฿0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of ฿0 Mil mean?
Thonburi Medical Center PCL (BKK:KDH) has a Research & Development of ฿0 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on Thonburi Medical Center PCL and its competitors.
Is Thonburi Medical Center PCL's Research & Development too high?
Thonburi Medical Center PCL's current Research & Development is ฿0 Mil. Overall, Thonburi Medical Center PCL has a GF Score™ of 88/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Thonburi Medical Center PCL's Research & Development compare to HCA and THC?
Thonburi Medical Center PCL's Research & Development of ฿0 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Healthcare Providers & Services company?
A good Research & Development depends on the Healthcare Providers & Services industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Thonburi Medical Center PCL and its competitors. Thonburi Medical Center PCL's current Research & Development is ฿0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Thonburi Medical Center PCL stock overvalued right now?
Based on GuruFocus' analysis, Thonburi Medical Center PCL (BKK:KDH) is currently considered Modestly Undervalued. The stock's GF Value™ is ฿92.61, compared to a current price of ฿83.25 — trading 10.1% below its estimated fair value. The current Research & Development is ฿0 Mil. Thonburi Medical Center PCL's overall GF Score™ is 88/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Thonburi Medical Center PCL (BKK:KDH), the current Research & Development is ฿0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Thonburi Medical Center PCL (BKK:KDH) Overvalued in 2026?

Based on GuruFocus' analysis, Thonburi Medical Center PCL stock appears to be undervalued. The current stock price of ฿83.25 is trading 10.1% below its estimated GF Value™ of ฿92.61. GuruFocus considers Thonburi Medical Center PCL to be Modestly Undervalued.

Key valuation signals for BKK:KDH:

  • Research & Development: ฿0 Mil
  • GF Value™: ฿92.61 vs. price of ฿83.25 (10.1% below fair value)
  • GF Score™: 88/100

No single metric tells the full story. See the BKK:KDH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Thonburi Medical Center PCL Business Description

Address 337, Somdet Prachao Taksin Road, Samrae Sub-district, Thonburi District, Bangkok, THA, 10600
Thonburi Medical Center PCL is a Thailand-based company. The company is engaged in the operation of the hospital business. The company provides medicines and medical supplies, medical services, and patient rooms. Its business operations involve a single industry segment, the hospital, and is carried on in a single geographic area in Thailand.
88GF Score

Get the complete analysis for BKK:KDH

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

฿83.25
Price
฿92.61
GF Value